Capstan brings surgical robot to valve replacement [Yahoo! Finance]
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Yahoo! Finance
Capstan Medical says it has notched a first in the treatment of structural heart disease, employing a robot to implant two people with mitral valve replacement devices. Current treatment options for heart valve disease exclude too many patients who are not good candidates for existing procedures, said Capstan CEO Maggie Nixon, and the company hopes its approach will provide them with a new alternative. The Santa Cruz, California-based startup is developing a valve implant, catheter and robotic delivery platform to expand structural heart intervention to a broader group of people. “There need to be more percutaneous, minimally invasive options to help treat valve disease,” Nixon said in an interview. The first two patients in Capstan's human trial recently were successfully treated for mitral regurgitation , where blood leaks back to the heart because the valve does not close properly. Development of minimally invasive procedures to address mitral and tricuspid disease has l
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- 4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026 [Yahoo! Finance]Yahoo! Finance
- Relief Cardiovascular Appoints Harry Rowland as Chairman of the Board [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.MarketBeat
- Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Wells Fargo & Company.MarketBeat
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
EW
Earnings
- 10/30/25 - Beat
EW
Sec Filings
- 12/12/25 - Form 4
- 12/12/25 - Form 4
- 12/12/25 - Form 4
- EW's page on the SEC website